Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'FcγRII blocking' (anti-TLX) alloantibody

Clinical Transplantation

Volumn 10, Issue 5, 1996, Pages 455-460

  Padányi, Ágnes ^a   Gyódi, Éva ^a   Rajczy, Katalin ^a   Perner, Ferenc ^b   Petrányi, Gyözö G ^a  

^a National Institute of Haematology and Immunology Budapest   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Alloantibody; Immunoregulation; Kidney transplant; Transfusion effect

Indexed keywords

ALLOANTIBODY; BLOCKING ANTIBODY; CYTOTOXIC ANTIBODY; HLA ANTIBODY;

ARTICLE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL RATE;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD; CYTOTOXICITY, IMMUNOLOGIC; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; ISOANTIBODIES; ISOANTIGENS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; RECEPTORS, IGG; RETROSPECTIVE STUDIES; ROSETTE FORMATION;

EID: 0029961468     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. LAGAAIJ EL, HENNEMANN IPH, RUIGROK M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989: 321: 701.
2. CLAAS FH, LAGAAIJ EL, VAN ROOD JJ. Immunological consequences of blood transfusions. Schweiz Med Wschr 1991: 121 (Sppl 43) 70.
3. DE WAAL LP, VAN TWUYVER E. Blood transfusion and allograft survival: Is mixed chimerism the solution for tolerance induction in clinical transplantation? Immunology 1991: 10: 417.
4. LAGAAIJ EL, RUIGROK MB, VAN ROOD JJ, et al. Blood transfusion induced changes in cell-mediated lympholysis: To immunize or not to immunize. J Immunol 1991: 147: 3348.
5. FEHRMAN I, RINGDÉN O, MOLLER E. Blood transfusions as pretreatment for kidney transplantation: Immunization rate and effect on cellular immune response in vitro. Transplantation 1983: 35: 339.
6. VANDERKERKHVE BA, VAN BREE S, ZHANG L, DATEMA G, ZANTVOORT F, CLAAS FHJ. Increase of donor-specific cytotoxic T lymphocyte precursors after transfusion. Transplantation 1989: 48: 672.
7. BURLINGHAM WJ. What is known about blocking factors in renal allograft recipients. Am J Reprod Immunol Microbiol 1988: 16: 15.
8. TERASAKI PI. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 1984: 137: 119.
9. BURLINGHAM WJ, SOLLINGER HW. Anti-idiotypes and transfusions. Transpl Proc 1988: 20: 1197.
10. MCLEOD AM, POWER DA, MANSON RJ. The transfusion effect in renal transplantation: A possible mechanism of action of transfusion effect in renal transplantation. Lancet 1982: II: 468.
11. MCLEOD AM, STEWART KN, URBANIAK S, CATTO GRD. Renal transplantation: HLA-linked, non-cytotoxic antibodies develop after blood transfusion. Clin Sci 1988: 74: 385.
12. SANDILANDS GP, COCKER JE, MCMILLAN MA, et al. Isolation and characterization of a high molecular weight lymphocyte Fcγ receptor-blocking factor associated with renal allograft survival. Clin Exp Immunol 1990: 82: 140.
13. FORWELL MA, COCKER JE, PEEL MG, BRIGGS JD, JUNOR BRJ, MACSWEEN RNM, et al. Correlation between high molecular weight serum Fcγ-receptor blocking factors and renal allograft survival. Transplant Proc 1985: XVII: 2572.
14. PADÁNYI Á, GYÓDI É, HORUZSKO A, et al. Temporary Tolerance or Suppressive Regulation Induced By Non MHC Alloantigens in Transplantation and Pregnancy, in. J Gergely et al. eds. Proc VIII. Immunol Congr, 1993: 807.
15. PERNER F, ALFOLDY F, JÁRAY J, HÍDVÉGI M, HEMANGSHU P. Preventive OKT3 treatment with cyclosporine (Sandimun) for second kidney transplantation. Transpl Int 1994: Suppl. 1: S255.
16. PADÁNYI Á, GYÓDI É, SÁRMAY G, et al. Functional and immunogenetic characterization of FcR-blocking antibody. Immunol Lett 1990: 26: 131.
17. RAY JG. NIH lymphocyte microcytotoxicity technique. NIAID Manual of Tissue Typing Techniques 1979-80. Bethesda NIH Publication No. 80-545, 1979: 39.
18. VAN ROOD JJ, VAN LEEUWEN A, KEUNING JJ, BLUSSE VAN OUD ALBLAS AA. The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens 1975: 5:73.
19. PETO RM, PIKE C, ARMITAGE P, et al. Design an analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. Brit J Cancer 1977: 35: 1.
20. OPELZ G. HLA antigen sensitisation: A problem in graft survival. Transplant Proc 1989: 21: 39.
21. CLAAS FH, VAN ROOD JJ. The hyperimmunized patient: from sensitisation toward transplantation. Transplant Int 1988: 1: 53.
22. PETRÁNYI GY, PADÁNYI Á, SZELÉNYI J, et al. The polymorphic human TLX-B/CD46/MCP system and its implications in transplantation and reproduction. Eur J Immunol 1995: 22: 147.
23. SHENTON BK, PROUD G, SMITH BM, TAYLOR RMR. Identification of immunosuppressive factors in plasma following multiple blood transfusions. Transpl Proc 1979: 11: 171.
24. HIBBERD AD, WOOD RA. Pregraft allogeneic platelets stimulate antidonor antibodies in the rat. Transplant Proc 1987: 19: 3091.
25. PETRI IB, LÔRINCZ A, BEREK I. Detection of Fc receptor-blocking antibodies in anti-Rh(D) hyperimmune gamma-globulin. Lancet 1984: II: 1478.
26. MCLEOD AM, CATTO GRD, STEWART KN, MATHER AJ, MA SON RJ, POWER DA, et al. Differential expression of trophoblast lymphocyte cross-reactive (TLX) antigens on T and B lymphocytes. Am J Repro Immunol Microbiol 1986: 10: 151.
27. TORU K, TORRY PS, MCINTYRE JA, FAULK WP. Trophoblast antigens in human seminal plasma. Am J Repro Immunol Microbiol 1988: 17: 91.
28. HORUZSKO A, GYÓDI É, RÉTI M, MAYER K, KASSAY M, PETRÁNYI GY. Selective effect of noncytotoxic blocking al- loantibodies produced after platelet transfusions on MLC, and mitogen and soluble antigen-induced responses of human lymphocytes. Transplantation 1990: 50: 497.
29. PADÁNYI Á, GYÓDI É, HORUZSKO A, RÉTI M, FÜLOP V, PETRÁNYI Gy. Functional importance of the TLX-B alloantigen system in reproductive immunity. In: TSUJI K, AIZAWA M, SASAZUKI T, eds. HLA 1991. Oxford Univ. Press 1992: 1005.
30. PETRÁNYI GY, PADÁNYI Á, KOTLÁN B, GYÓDI É, SZIGETVÁRI I, KASSAI M. Cellular and humoral immunologic factors for the protection of throphoblast and embryo in human. Regional Immunol 6: 306.